InsiderSignal.AI

InsiderSignal.ai

DNTH - Dianthus Therapeutics, Inc. /De/

Insider Sale by Savitz Ryan (EVP, CFO, CBO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

6 days ago, Savitz Ryan, serving as EVP, CFO, CBO at Dianthus Therapeutics, Inc. /De/ (DNTH), sold 8,224 shares at $89.84 per share, for a total transaction value of $738,844.00.

This sale represents a 100.00% decrease in Savitz Ryan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 9, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 10, 2026, 1 day after the trade was made.

Dianthus Therapeutics, Inc. /De/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Savitz Ryan

Savitz Ryan

EVP, CFO, CBO

Ryan Savitz is the Executive Vice President, Chief Financial Officer, and Chief Business Officer (EVP, CFO, CBO) at Dianthus Therapeutics, Inc. (DNTH), a clinical-stage biotechnology company focused on developing novel antibody complement therapeutics for severe autoimmune and inflammatory diseases, based in New York City and Waltham, Mass.[[1]](https://www.zoominfo.com/p/Ryan-Savitz/1296281737)[[2]](https://www.tipranks.com/experts/insiders/savitz-ryan)[[3]](https://www.sec.gov/Archives/edgar/data/1690585/000000000023012504/filename1.pdf) Savitz joined Dianthus in 2024 and has a strong background in investment banking, having served as Managing Director (2021-2022), Director (2020-2021), Vice President (2017-2020), and Associate (2013-2017) at Citi.[[1]](https://www.zoominfo.com/p/Ryan-Savitz/1296281737) Prior roles include positions at Bullish Bankers, Nittany Lion Fund, Convergent Wealth Advisors, and BlackRock.[[1]](https://www.zoominfo.com/p/Ryan-Savitz/1296281737) He holds a degree in Finance and Economics from Penn State University.[[1]](https://www.zoominfo.com/p/Ryan-Savitz/1296281737)

View full insider profile →

Trade Price

$89.84

Quantity

8,224

Total Value

$738,844.00

Shares Owned

0

Trade Date

Thursday, April 9, 2026

6 days ago

SEC Filing Date

Friday, April 10, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Dianthus Therapeutics, Inc. /De/

Company Overview

No company information available
View news mentioning DNTH

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5609642

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime